---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-019610"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2023-07-07T23:59:59+00:00"
generated_at: "2026-06-13T10:57:23.135495+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vistagen CFO Jerrold D. Dotson to retire by Aug 31, 2023; successor identified

## Summary
- CFO Jerrold D. Dotson intends to retire on or about August 31, 2023.
- Retirement not due to any disagreement with the company on operations or policies.
- Board has identified a potential successor, subject to completion of onboarding activities.
- Company will announce successor upon appointment.

## SEC filing metadata
- accession: 0001437749-23-019610
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2023-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000143774923019610/0001437749-23-019610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000143774923019610/vtgn20230706_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-019610
- JSON: https://secwatch.observer/filing/0001437749-23-019610.json
- Plain text: https://secwatch.observer/filing/0001437749-23-019610.txt

## Key facts
- Executive change
  Jerrold D. Dotson departed as Vice President and Chief Financial Officer at Vistagen Therapeutics, Inc..
  - Action: intends to retire
  - Role: Vice President and Chief Financial Officer
  source text: On July 7, 2023, Vistagen Therapeutics, Inc. (the “ Company ”) announced that Jerrold D. Dotson, CPA, Vice President and Chief Financial Officer (principal financial and accounting officer), intends to retire from the Company on or about August 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411685/000143774923019610/0001437749-23-019610-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.